Anika Therapeutics Inc.

(ANIK) Trade

By |

Profile

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company's product profile includes Orthobiologics, Dermal, Surgical and other of which Orthobiologics products generates maximum revenue to the company.

Contact Information

Website: www.anikatherapeutics.com
Email: investorrelations@anikatherapeutics.com
Main Phone: +1 781 457-9000
Address: 32 Wiggins Avenue
State: MA
City / Town: Bedford
Country: USA
Postal Code: 01730

Issuer Information

Exchange: NGS
CEO: Joseph G. Darling
Employees: 133
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company's product profile includes Orthobiologics, Dermal, Surgical and other of which Orthobiologics products generates maximum revenue to the company.

Contact Information

Website: www.anikatherapeutics.com
Email: investorrelations@anikatherapeutics.com
Main Phone: +1 781 457-9000
Address: 32 Wiggins Avenue
State: MA
City / Town: Bedford
Country: USA
Postal Code: 01730

Issuer Information

Exchange: NGS
CEO: Joseph G. Darling
Employees: 133
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 38.58 $ -1.61 (-4.01%)
Last Price 38.58 Change $ -1.61 Change % -4.01 Tick N/A
Bid 38.53 Bid Size 200.00 Ask 38.58 Ask Size 100.00
Open 40.00 High 40.05 Low 38.53 Prev Close 40.19
Last Trade Volume 67,273 52 Wk Hi 44.95 52 Wk Low 29.01
Market Cap 548.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 14,206,920.00 EPS (TTM) 2.05 PE Ratio 19.70 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 20
Number of Buys 0 9
Number of Sells 0 11
Net Activity 0 -31698
Last 10 Buys Shares
Kevin W. Quinlan 1,000
William J. Mrachek 1,000
Last 10 Sell Shares
Richard Hague 1,000
Charles H. Sherwood 1,000
Charles H. Sherwood 1,000
Charles H. Sherwood 1,000
Charles H. Sherwood 1,000
Charles H. Sherwood 1,000
Charles H. Sherwood 1,000
Charles H. Sherwood 1,000
Charles H. Sherwood 1,000
Charles H. Sherwood 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 68 68 68 68
Low Target Price Estimate 39 39 39 39
Mean Target Price Estimate 53.5 53.5 53.5 53.5
Standard Deviation 20.51 20.51 20.51 20.51
Date of Most Recent Estimate 05/04/18 05/04/18 05/04/18 05/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 2 2